Hemostatic Management in Pediatric Patients With Type I von Willebrand Disease Undergoing Oral Surgery: Case Report and Literature Review

被引:4
作者
Bornert, Fabien [1 ]
Clauss, Francois [2 ]
Gros, Catherine-Isabelle [1 ]
Faradji, Albert [3 ]
Schmittbuhl, Matthieu [4 ]
Maniere, Marie-Cecile [2 ,5 ]
Feki, Ahmed [1 ]
机构
[1] Univ Hosp, Fac Dent, Dept Oral Med & Oral Surg, F-67000 Strasbourg, France
[2] Univ Hosp, Fac Dent, Dept Pediat Dent, F-67000 Strasbourg, France
[3] Univ Hosp, Fac Dent, Dept Hematol, Reg Ctr Treatment Inherited Bleeding Disorders, F-67000 Strasbourg, France
[4] Univ Hosp, Fac Dent, Dept Dentomaxillofacial Radiol, F-67000 Strasbourg, France
[5] Univ Hosp, Fac Dent, Reference Ctr Oral Manifestat Rare Dis, F-67000 Strasbourg, France
关键词
FACTOR-VIII; CLASSIFICATION; PATHOPHYSIOLOGY; DESMOPRESSIN; EXTRACTIONS; DIAGNOSIS; THERAPY; ANTIGEN; VWD;
D O I
10.1016/j.joms.2011.03.073
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Von Willebrand disease (vWD) (Online Mendelian Inheritance in Man 193400) is a hematologic condition characterized by reduced platelet adhesiveness linked to factor VIII (FVIII) and von Willebrand factor (vWF) deficiencies.(1,2) vWF, otherwise known as factor VIII-related protein is a large glycoprotein synthesized by endothelial cells and megakaryocytes, and represents the major component of the FVIII-vWF multimeric complex. 3 vWF has bridging molecular functions between vessel walls and platelets. vWF level can be measured by immunoassay as plasmatic levels of vWF antigen (vWF: Ag).(4,5) A clinical classification of the different vWD subtypes has been developed according to the levels and patterns of the vWF antigen multimers.(6) Type I vWD represents 50% to 75% of cases and is characterized by quantitative reduction of all multimers, divided into autosomal dominant and recessive forms, with the protein complex FVIII/vWF appearing qualitatively normal.(7) An important clinical variability in the vWD type is observed, with the vWF plasmatic half-time modulating the vWD phenotype, and mild, moderate or severe type I vWD has been described.(8) The most severe reduction is observed in homozygous patients. Type II vWD is divided into IIA, IIB, IIC, IIM, and IIN forms and is characterized by qualitative defects of FVIII/vWF complex.(1) Many allelic variants of subtypes IIA, IIB, and III have been described, showing the genetic heterogeneity of the condition.(1) Type III vWD represents the most severe and rare form of the disease with very low or undetectable levels of vWF.(9) The genetic mutations involved in type 3 vWD exhibit high variability and consist mainly of large partial vWF gene deletions, with insertions resulting in frame shift mutations and splice site mutations.(10) vWD corresponds to the hemorrhagic risk during oral surgery and requires hematologic conditioning in the context of a multidisciplinary team that must include the pediatrician, pediatric dentist, radiologist, hematologist, anesthesiologist, and oral maxillofacial surgeon.(11) However, few cases of pediatric oral surgery in a vWD context have been reported.(12) In the present report, we describe the case of a young girl with vWD type I and 2 impacted anistrophic cone-shaped mesiodens in the premaxilla. Completed by a review of the published data, the aims of the present clinical report are to highlight the importance of the multidisciplinary management consisting of careful hematologic conditioning, atraumatic surgical treatment, and clinical follow-up.
引用
收藏
页码:2086 / 2091
页数:6
相关论文
共 50 条
  • [21] Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report
    Lapic, Ivana
    Antolic, Margareta Radic
    Rogic, Dunja
    Bekic, Sara Dejanovic
    Herak, Desiree Coen
    Bilic, Ernest
    Zadro, Renata
    LABORATORY MEDICINE, 2023, 54 (04) : 434 - 438
  • [22] Management of carotid body tumor in pediatric patients: A case report and review of the literature
    Ifeoluwa, Apanisile
    Lazar, Istvan
    Szovordi, Eva
    Karosi, Minas
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2017, 93 : 47 - 52
  • [23] Knee replacement surgery in a patient with acquired von Willebrand disease: a case study with recommendations for patient management
    Alvarez Roman, Maria Teresa
    Rivas Pollmar, Maria Isabel
    de la Corte-Rodriguez, Hortensia
    Gomez-Cardero, Primitivo
    Rodriguez-Merchan, E. Carlos
    Gutierrez-Alvarino, Mar
    Garcia-Perez, Eduardo
    Martin-Salces, Monica
    Zagrean, Damaris
    Butta-Coll, Nora V.
    Jimenez-Yuste, Victor
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (03): : 1681 - 1686
  • [25] Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery
    Franchini, M
    De Gironcoli, M
    Lippi, G
    Manzato, F
    Brazzarola, P
    Bottura, D
    Aprili, G
    Gandini, G
    HAEMOPHILIA, 2002, 8 (02) : 142 - 144
  • [26] Endoscopic management of pancreaticopleural fistula in a pediatric patient A case report and literature review
    Yang, Jing
    Lu, Lei
    Jin, Hang-bin
    Yang, Jian-feng
    Zhang, Xiao-feng
    MEDICINE, 2020, 99 (23)
  • [27] Report Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor
    Batsuli, Glaivy
    Zimowski, Karen L.
    Carroll, Rachel
    White, Michael H.
    Woods, Gary M.
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (03) : 724 - 727
  • [28] Oral Lichenoid Drug Eruption: A Report of a Pediatric Case and Review of the Literature
    Woo, Victoria
    Bonks, Julia
    Borukhova, Lyubov
    Zegarelli, David
    PEDIATRIC DERMATOLOGY, 2009, 26 (04) : 458 - 464
  • [29] THE INCIDENCE OF IMPAIRED BINDING CAPACITY OF VON WILLEBRAND FACTOR TO COLLAGEN TYPES I AND III IN PATIENTS WITH TYPE 1 VON WILLEBRAND DISEASE
    Koloskov, A., V
    Vasileva, M. Yu
    Philippova, O., I
    Chernova, E., V
    Beliaeva, E. L.
    Marchenko, V. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2023, 68 (01): : 62 - 69
  • [30] Current Management of Patients with Severe von Willebrand Disease Type 3: A 2012 Update
    Federici, Augusto B.
    James, Paula
    ACTA HAEMATOLOGICA, 2012, 128 (02) : 88 - 99